chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had a rash right after vaccine arm and cheeks rosy and rash primarily on arms and chest.  Lasted about 15-20 minutes and left vaccination area.  Later that evening fatigue, chills, temp and body aches were extreme.  dizzy and nausea with standing. unable to work and could only hold down minimal fluid or food.  Next day same with night sweats and now has a cough and sore throat.  Body aches have decreased.  Patient reports having COVID 45 days ago but was nothing like these symptoms.
Loud ringing in ears still happening; Got increasingly dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Got increasingly dizzy) and TINNITUS (Loud ringing in ears still happening) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced DIZZINESS (Got increasingly dizzy). On 18-Apr-2021, the patient experienced TINNITUS (Loud ringing in ears still happening). At the time of the report, DIZZINESS (Got increasingly dizzy) and TINNITUS (Loud ringing in ears still happening) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medications are provided. treatment to the events not reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-155602 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: follow up received on 20-may-2021, it does not contain any new information.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-155602:friend of a friend
Caller had the second shot 16Jan2021 and was tested today 20Jan2021 and now she is back positive.; Caller had the second shot 16Jan2021 and was tested today 20Jan2021 and now she is back positive.; This is a spontaneous report from a contactable consumer (patient).  A 49-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) for COVID-19 immunization on 26Dec2020 (first dose; Batch/lot number: EL5738) at single dose into right arm and on 16Jan2021 (second dose LOT EL3248) at single dose into left arm. Medical history was none.  Concomitant medication included gummy bear vitamins, no further details provided. Patient did her first COVID test on 16Dec2020, prior to getting the vaccination, and was negative. Patient got the first dose of the vaccine on 26Dec2020 and on 30Dec2020 tested positive (via COVID-19 PCR test) for Covid. She was tested negative on 03Jan2021 and 04Jan2021 (both COVID-19 PCR tests). Patient had the second shot on 16Jan2021 and COVID-19 PCR test on 20Jan2021 was back positive. Patient clarified she got the injection twice, and each time she has gotten it and gotten tested after, each test was showing positive. She clarified that she went to a nursing home and was tested every 14 days when she went to see her mom and all times prior to getting the vaccine doses she was negative. She said her first dose of the vaccine was on 26Dec2020, then four days after that it was time to go get tested to go see her mom and the test was positive within no time it lights up. She said as a medical worker (she was a patient registration clerk at the emergency room- ER) she can wait 5 days after that for it to come up after being positive and after that if it was showing up negative she had to wait 24 hours to confirm negative test and repeated the test within 24 hours, which was negative too. She got the second dose on 16Jan2021 and then she went to go get tested to go back to the nursing home and again it came back positive. Outcome of the event was unknown. Patient wanted to know if this was a herd immunity vaccine and if the vaccine had covid in it.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021051224 same patient, different dose
On 12/4/21, I calculated this child's age to be 11 years and gave him a pediatric dose of Pfizer, 0.2ml.  This child was 12 at the time of his vaccination on 12/4/21.  Today I checked the Immunization Registry, and found that this child received a first dose of Pfizer 0.3ml  on 10/13/21.  The child waited 15 minutes after receiving the Pfizer 0.2ml dose on 12/4/21 and no adverse reaction was noted or reported during that time.   The CDC Interim Revaccination guidelines dated 12/01/2021, state do NOT repeat dose.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 63-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 05Mar2021 as dose 1, single (Lot number: EN6206), in left arm and on 26Mar2021 as dose 2, single (Lot number: ER8734) at the age of 62 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "known allergies: Sulfa" (unspecified if ongoing), notes: known allergies: Sulfa; "known allergies: mango" (unspecified if ongoing), notes: known allergies: mango. There were no concomitant medications.  The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown Results; (08Jun2022) Positive, notes: Today's test came up strongly positive within 2 minutes' am using the iHealth brand test. Therapeutic measures were taken as a result of vaccination failure, covid-19.  No follow-up attempts are possible. No further information is expected.
Patient stopped by to the clinic after 1 hr from the initial vaccination stating that she was not feeling well. Patient looked pale and bilateral fingers were feeling not well. Patient was awake, alert oriented and denied difficulty in breathing or sensation of tongue swelling or chest tightness or sensation of throat closing. BP were 120/70, HR62-65, SatO2 100 %. Patient sat down in the clinic chair after few min, she started feeling much calmer and reported she feels better.
Initial unsolicited report received from a non-healthcare professional on 23 November 2015. This case is linked with 2015SA194971 (same reporter). This case involves a male patient who was vaccinated with a dose of FLUZONE HD (batch number, expiration date, dose, dose number, were not reported) on an unspecified date. The patient's medical history and concomitant medication were not reported. On an unspecified date, following the vaccination, the patient had Guillain barre. Laboratory investigations and corrective treatments were not reported. The outcome of the event was not reported. Upon internal review, the case was considered to be serious due to important medical event: Guillain Barre Follow-up information received from a consumer on 11 January 2016. It was reported that in October 2015 (unspecified date) patient was vaccinated with a dose of FLUZONE HD. Pre-existing physician-diagnosed allergies, birth defect, medical conditions were reported none. Patient had not taken any vaccination within four-weeks prior to administration of FLUZONE HD. Patient was hospitalized on an unspecified date which resulted in prolongation of hospital. List of documents held by sender: none. Required emergency room/ doctor visit. It was reported that the patient was not recovered and stated that pateint was permanently disabled. Sender's Comments: Follow-up received on 11-Jan-2016, does not change the medical assessment of the case. Guillain Barre Syndrome is listed with INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE. This case lacks information about time to onset from vaccination, hence temporal association cannot be established. Also, investigation results (electromyogram, CSF cell counts and units for protein levels, tendon reflex examination) and etiological investigation results in particular infectious work-up are not provided. Based on the limited available information, case cannot be assessed for now.
Terrible pain and spasms in his left arm; Spasms spread to his chest as well / pain and muscle spasms are constant and very uncomfortable; Chest muscles squeeze and release repeatedly; Arm trembles and he states he can "see the muscles in the arm tremble; Occurs all the way down his left arm and it feels like tendinitis; Unable to sleep; Arm constantly aches and throbs; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Terrible pain and spasms in his left arm), MUSCLE SPASMS (Spasms spread to his chest as well / pain and muscle spasms are constant and very uncomfortable), CHEST DISCOMFORT (Chest muscles squeeze and release repeatedly), TREMOR (Arm trembles and he states he can "see the muscles in the arm tremble) and TENDONITIS (Occurs all the way down his left arm and it feels like tendinitis) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (Terrible pain and spasms in his left arm), MUSCLE SPASMS (Spasms spread to his chest as well / pain and muscle spasms are constant and very uncomfortable), CHEST DISCOMFORT (Chest muscles squeeze and release repeatedly), TREMOR (Arm trembles and he states he can "see the muscles in the arm tremble), TENDONITIS (Occurs all the way down his left arm and it feels like tendinitis), INSOMNIA (Unable to sleep) and PAIN (Arm constantly aches and throbs). At the time of the report, PAIN IN EXTREMITY (Terrible pain and spasms in his left arm), MUSCLE SPASMS (Spasms spread to his chest as well / pain and muscle spasms are constant and very uncomfortable), CHEST DISCOMFORT (Chest muscles squeeze and release repeatedly), TREMOR (Arm trembles and he states he can "see the muscles in the arm tremble), TENDONITIS (Occurs all the way down his left arm and it feels like tendinitis), INSOMNIA (Unable to sleep) and PAIN (Arm constantly aches and throbs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication information is not provided.  Patient took some pain medications and muscle relaxants but it just help to sleep at night but the pain doesn't go away.
p/vax WBC, liver enzyme, bilirubin, SGOT & allergic rxn & felt tired & weak;went to ER & hosp for couple days;
Systemic: Body Aches Generalized-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: hard to walk-Medium
Positive erythema 15x16cm left thigh, not tender, + warmth and itch. Continue TYLENOL and IBUPROFEN; BENADRYL for itching.
got a third dose; got the second greater than 6 months from the first; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 0.5 ml of 1st dose of Shingrix intramuscularly on 28th February 2020).   On 30th July 2022, the patient received the 3rd dose of Shingrix (intramuscular) .5 ml. On 19th July 2021, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On 19th July 2021, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On 30th July 2022, the patient experienced extra dose administered. On an unknown date, the outcome of the drug dose administration interval too long and extra dose administered were unknown.   Additional Information: GSK receipt date: 01-Aug-2022 Reporter's comment: The pharmacist stated that they had a patient that got 3rd dose of Shingrix vaccine. The patient also got the 2nd dose of shingrix vaccine greater than 6 months from the 1st vaccine (inappropriate schedule of vaccine).  The pharmacist did not had the lot or expiration of the vaccines. The reporter did not consent to follow-up. Additional supportive information: The patient received the 2nd dose of Shingrix in unknown arm later the recommended interval, which led to lengthening of vaccine schedule. The patient got the 3rd dose of Shingrix in left arm, which led to extra dose administered.
Information has been received from a physician's assistant concerning a female patient, who on an unspecified date was vaccinated with a second 0.5 ml dose of GARDASIL (Lot # not reported). The physician's assistant reported that the patient received her second dose and had localized swelling and swelling of the interior lymph node in her neck. It was reported that the patient had not received treatment for the adverse events. The patient did not seek medical attention. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
Janssen COVID-19 Vaccine EUA Chills and muscle aches began  5.5 hours after vaccine and last for about 3 hours. Extreme chills and aches for 1.5 of those 3 hours.  Fever rose to 100 degrees and fell within those 3 hours. Next day experienced minor heachache, body aches, fatigue for entire day. 56 hours after vaccine experienced red itchy bumps across stomach and inside elbows.
Information has been received from a nurse practitioner concerning an 11 or 12 year old male with a history of an enlarged spleen and splenectomy (age 6 or 9 years) and numerous vaccine (names unk) who was vaccainted with a dose of Pneumococcal 23v polysaccharide vaccine (dose and date not reported). Subsequently about 2 years ago, the pt experienced vesicular and burning dermatones that was diagnosed as shingles. The nurse practitioner thought the pt was going to come back to the office for a recheck the following week but does not remember seeing this pt again. The nurse practitioner dose not remember a lot of details from this case because it was from about two years ago. At the time of this report, the pts outcome was unk. No product quality complaint was involved. Shingles was considered to be an other important medical event (OMIC). Additional information has been requested.
Allergic reaction with rash, itching, localized fever, and a knot at injection site. Treated with ice and topical hydrocortisone cream 1% Allergic reaction showed up at 24 hours and continued through the 4th day.
This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 29Mar2021(at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity and allergy to macadamia nuts. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included buspirone (MANUFACTURER UNKNOWN), adults vitamins and NSRI prescription from an unknown date for unspecified indication and unknown if ongoing. The patient previously took cefalexin (KEFLEX) and codeine (MANUFACTURER UNKNOWN) on an unknown date for an unknown indication and experienced drug allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 08Mar2021(at the age of 50-years-old) as a single dose for COVID-19 immunisation. On 29Mar2021, several hours after the vaccination the patient experienced hemorrhoids and lasted roughly two days, then resolved. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the reported event and included treatment with the product preparation H cream. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event hemorrhoids was recovered on 31Mar2021, after the duration of 2 days. No follow-up attempts are needed. No further information is expected.
Diarrhea for 5days; This is a spontaneous report from a contactable consumer (patient). A 51-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 19Mar2021 12:00 AM (at the age of 51-year-old) as dose 2, single for covid-19 immunisation. Medical history included surgery from an unknown date and unknown if ongoing. Other medical history was reported as no. Patient did not have allergies to medications, food, or other products. Concomitant medication(s) included paracetamol (TYLENOL) taken for an unspecified indication, start and stop date were not reported. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration, administered in Arm Left on 26Feb2021 12:00 AM (at the age of 51-year-old) as dose 1, single for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. List of any other medications the patient received within 2 weeks of vaccination: Tylenol, had surgery. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced diarrhea for 5days on 19Mar2021 02:00. The adverse event resulted in Emergency room/department or urgent care. Therapeutic measures were taken as a result of diarrhea for 5days, patient reported doctors said just for it to go away. The outcome of event diarrhoea was not recovered.  No follow-up attempts are needed, information about lot/batch number cannot be obtained.
I noticed a rash with pain under my ribcage, I went to a local Urgent Care seeking treatment. They sent me to the emergency room where they confirmed that I did not have pneumonia. They tested me COVID-19, took, x-rays, bloodwork, EKG. My test for COVID-19 was negative, x-rays were negative for pneumonia, EKG was normal, bloodwork was normal. I was prescribed Acyclovir for the shingles and given a Z-pack. I am now dealing with Postherpetic neuralgia, I am taking medication to help with the pain while the nerves heal.
Patient tested positive for COVID-19 on 05/20/2021, and received monoclonal antibody therapy on 05/21/2021.
Right arm swollen, tense, slightly red and warm but non-tender. 4cm in circumference between right arm and left.
Admission date 8/2/21. Had both doses Pfizer vaccine, last dose 4/5/21. Presented with generalized weakness, dehydration and AMS due to UTI. COVID test positive on 8/2 and 8/7/21. No treatment for COVID because pt had no SOB or hypoxia. Did receive IV fluids and antibiotics for UTI. Discharged 8/6/21.
Blood Pressure would spike and go back to normal. Spiking for maybe 3 to 4 minutes. Headache would come right after. This lasted approximately 2 weeks. At one point I told my wife that she may need to call 911 due to me thinking I was going to have a heart attack or  stroke.
APAP given p/inject 12NOV91 fussy through most of evening; crying some next day cried hard & vigorously for hrs 3-4 1/2; t98.8 APAP unsuccessful in calming 15NOV91 pt seems fine;
I got shingles shot/Suspected Vaccination Failure; Got is again; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, several years after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: I got shingles shot/Suspected Vaccination Failure) (serious criteria GSK medically significant) and shingles (Verbatim: Got is again). The outcome of the vaccination failure was not reported and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK receipt date: 03-MAR-2023 The case  was received from the patient via interactive digital media. The patient got shingles shot several years ago then within 2 weeks caught shingles. The patient took pictures of it. The patient was in small town, the physician was gone but nurse was there, the patient got shingles. The patient stated there was no record and got it again in few months ago still had issue from it. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Patient presents to the ED on 5/3/23 with difficulty in breathing, fever, chills, and respiratory distress. Also mental status decline. Tested positive for COVID on 5/3/23. The patient was admitted to critical care and was put on oxygen support. and treated. He was discharged home on 5/15/23.
This spontaneous report was received from medical assistant via RMPDC (case # MK55569) on 30-DEC-2013 and referred to a 59 year old female patient with positive human papillomavirus (HPV). The patient's relevant medical history, concomitant medications and past drug history were unknown. On 19-SEP-2013, the patient was vaccinated with GARDASIL (lot # J007354, expiration date: 20-FEB-2016) (dose and route of administration not reported) for positive human papillomavirus, that was recently recalled. It was unknown if there was any relevant laboratory data. As of 30-DEC-2013 it was unknown if the patient continued to receive GARDASIL. The outcome of receiving GARDASIL that had been recalled and for receiving GARDASIL for positive HPV was unknown. This is one of several reports from the same reporter. This case is linked with MARRS # 1401USA000047 (Same Reporter Link). Additional information has been requested.
Patient still has soreness and stiffness after 2 mos. post administration. General arm soreness has subsided but it's still painful to the touch.
Hoarse throat, chills, body aches, inability to sleep, Heart rate 124 at midnight while in bed and trying to sleep. Worst night in a long time. Couldn?t get warm. Like getting the full on flu! Doing much better this morning.
redness and swelling on the upper right arm; redness and swelling on the upper right arm; This is a spontaneous report from a contactable pharmacist (patient's parent) received via a sales representative. A male patient of an unspecified age started to receive meningococcal group b rlp2086 (TRUMENBA), via an unspecified route of administration from an unspecified date at a single dose for immunization. The patient medical history and concomitant medications were not reported. The patient experienced redness and swelling on the upper right arm on an unspecified date. Events took place after use of product. The outcome of the events were unknown.  Information on the lot/batch number has been requested.
Lt arm red swollen, itching shoulder to elbow. welt swelling 9/26/15 the symptoms started.
started in my nose. I felt like I had worms inside my nostrils it traveled to my ear into my head. It felt like it was inside my brain. I was unable to talk drive or care for myself for about a week. It localized in my forehead. Im still sick w no answers. I have sinititis and allergies normally. This is horrible my income went to 1/3 for the year. I'm about to get fired from my job and lose everything and no doctor can give me any answers. Please help, thanks